Rituximab vs Titanium Dioxide

## Rituximab vs Titanium Dioxide: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Titanium Dioxide**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Titanium Dioxide — N/A.

## Chemical Properties

**Type**: Rituximab — Antibody; Titanium Dioxide — Small molecule.